XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.24.3

STOCK-BASED COMPENSATION | 9 Months Ended
--- | ---
Sep. 30, 2024
STOCK-BASED COMPENSATION |
STOCK-BASED COMPENSATION | 15. STOCK-BASED COMPENSATION Before the Merger, Bridge and Legacy Dime granted share-based awards under their respective stock-based compensation plans, (collectively, the “Legacy Stock Plans”), which are both subject to the accounting requirements of ASC 718. The Company no longer makes grants under the Legacy Stock Plans. Awards outstanding under the Legacy Stock Plans will continue to remain outstanding and subject to the terms and conditions of the Legacy Stock Plans. In May 2021, the Company’s shareholders approved the Dime Community Bancshares, Inc. 2021 Equity Incentive Plan (the “2021 Equity Incentive Plan”) to provide the Company with sufficient equity compensation to meet the objectives of appropriately incentivizing its officers, other employees, and directors to execute our strategic plan to build shareholder value, while providing appropriate shareholder protections. An additional 1,185,000 shares of common stock were reserved to be issued under the 2021 Equity Incentive Plan following shareholder approval at the Annual Meeting of Shareholders on May 23, 2024. At September 30, 2024, there were 1,462,229 shares reserved for issuance under the 2021 Equity Incentive Plan. Stock Option Awards The following table presents a summary of activity related to stock options granted under the Legacy Stock Plans, and changes during the period then ended: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ |  | ​ | ​ |  | Weighted- |  | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted- | ​ | Remaining | ​ | Aggregate
​ | ​ | Number of | ​ | Average Exercise | ​ | Contractual | ​ | Intrinsic
(Dollars in thousands except share and per share amounts) |  | Options |  | Price |  | Years |  | Value
Options outstanding at January 1, 2024 | ​ | 26,995 | ​ | $ | 35.39 | ​ | 5.2 | ​ | ​ | —
Options exercised | ​ | — | ​ |  | — | ​ | ​ | ​ | ​ | ​
Options forfeited | ​ | — | ​ |  | — | ​ | ​ | ​ | ​ | ​
Options outstanding at September 30, 2024 |  | 26,995 | ​ | $ | 35.39 |  | 4.5 | ​ | $ | —
Options vested and exercisable at September 30, 2024 |  | 26,995 | ​ | $ | 35.39 |  | 4.5 | ​ | $ | —
​ Information related to stock options during each period is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | Nine Months Ended | ​
​ | ​ | September 30, | ​ | September 30, | ​
(In thousands) |  | 2024 |  | 2023 | ​ | 2024 |  | 2023 | ​
Cash received for option exercise cost | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​
Income tax (expense) benefit recognized on stock option exercises | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | — | ​
Intrinsic value of options exercised | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | — | ​
​ The range of exercise prices and weighted-average remaining contractual lives of both outstanding and vested options (by option exercise cost) as of September 30, 2024 were as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Outstanding Options | Vested Options
​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | Weighted
​ | ​ | ​ | ​ | Average | ​ | ​ | ​ | Average
​ | ​ | Number | ​ | Contractual | ​ | Number | ​ | Contractual
​ | ​ | of | ​ | Years | ​ | of | ​ | Years
​ |  | Options |  | Remaining |  | Options |  | Remaining
Exercise Prices: |  |  |  |  |  |  |  |
$34.87 |  | 10,061 |  | 5.4 |  | 10,061 |  | 5.4
$35.35 |  | 9,802 |  | 4.4 |  | 9,802 |  | 4.4
$36.19 |  | 7,132 |  | 3.4 |  | 7,132 |  | 3.4
Total |  | 26,995 |  | 4.5 |  | 26,995 |  | 4.5
​ Restricted Stock Awards The Company has made RSA grants to outside Directors and certain officers under the Legacy Stock Plans and the 2021 Equity Incentive Plan. Typically, awards to outside Directors fully vest on the first anniversary of the grant date, while awards to officers vest over a pre-determined requisite period. All awards were made at the fair value of the Company’s common stock on the grant date. Compensation expense on all RSAs is based upon the fair value of the shares on the respective dates of the grant. The following table presents a summary of activity related to the RSAs granted, and changes during the period then ended: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ |  | Weighted-
​ | ​ | ​ | ​ | Average
​ | ​ | Number of | ​ | Grant-Date
​ |  | Shares |  | Fair Value
Unvested allocated shares outstanding at January 1, 2024 | ​ | 356,795 | ​ | $ | 26.88
Shares granted |  | 320,730 | ​ |  | 20.63
Shares vested | ​ | (169,290) | ​ | ​ | 26.94
Shares forfeited |  | (13,648) | ​ |  | 24.62
Unvested allocated shares outstanding at September 30, 2024 |  | 494,587 | ​ | $ | 22.86
​ Information related to RSAs during each period is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | Nine Months Ended | ​
​ | ​ | September 30, | ​ | September 30, | ​
(In thousands) |  | 2024 |  | 2023 | ​ | 2024 |  | 2023 | ​
Compensation expense recognized | ​ | $ | 1,542 | ​ | $ | 604 | ​ | $ | 4,419 | ​ | $ | 2,924 | ​
Income tax expense recognized on vesting of RSAs | ​ |  | (49) | ​ |  | (72) | ​ |  | (317) | ​ |  | (184) | ​
​ As of September 30, 2024, there was $7.5 million of total unrecognized compensation cost related to unvested RSAs to be recognized over a weighted-average period of 1.8 years. Performance-Based Share Awards The Company maintains a long-term incentive award program (“LTIP”) for certain officers, which meets the criteria for equity-based accounting. For each award, threshold (50% of target), target (100% of target) and stretch (150% of target) opportunities are eligible to be earned over a three-year performance period based on the Company’s relative performance on certain goals that were established at the onset of the performance period and cannot be altered subsequently. Shares of common stock are issued on the grant date and held as unvested stock awards until the end of the performance period. Shares are issued at the stretch opportunity in order to ensure that an adequate number of shares are allocated for shares expected to vest at the end of the performance period. Compensation expense on PSAs is based upon the fair value of the shares on the date of the grant for the expected aggregate share payout as of the period end. The following table presents a summary of activity related to the PSAs granted, and changes during the period then ended: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ |  | Weighted-
​ | ​ | ​ | ​ | Average
​ | ​ | Number of | ​ | Grant-Date
​ |  | Shares |  | Fair Value
​ | ​ | ​ | ​ | ​ | ​
Maximum aggregate share payout at January 1, 2024 | ​ | 222,240 | ​ | $ | 20.64
Shares granted |  | 96,049 | ​ |  | 18.61
Shares forfeited | ​ | (37,335) | ​ | ​ | 26.53
Shares vested | ​ | (12,371) | ​ | ​ | 29.97
Maximum aggregate share payout at September 30, 2024 |  | 268,583 | ​ | $ | 18.67
Minimum aggregate share payout |  | — | ​ | ​ | —
Expected aggregate share payout |  | 257,565 | ​ | $ | 18.32
​ Information related to PSAs during each period is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | Nine Months Ended
​ | ​ | September 30, | ​ | September 30,
(In thousands) |  | 2024 |  | 2023 | ​ | 2024 |  | 2023
Compensation expense (benefit) recognized | ​ | $ | 414 | ​ | $ | (66) | ​ | $ | 563 | ​ | $ | 274
Income tax expense recognized on vesting of PSAs | ​ |  | — | ​ |  | — | ​ |  | (52) | ​ |  | —
​ As of September 30, 2024, there was $3.1 million of total unrecognized compensation cost related to unvested PSAs based on the expected aggregate share payout to be recognized over a weighted-average period of 2.0 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration